President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...

More than 10% of the staff working for the federal Substance Abuse and Mental Health Services Administration were fired this ...

A federal judge Thursday found the Trump administration violated a restraining order meant to stop it from suspending ...

The Trump administration began layoffs at the Internal Revenue Service on Thursday, multiple outlets reported—leading to ...

The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The committee was designed to reduce barriers to care for people of color, LGBTQ+ people and rural Americans. A new executive ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Reportedly the biggest layoff of probationary federal workers so far under new Trump administration orders is underway today at the Internal Revenue Service.

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...